This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Academia Sinica, Chang Gung Medical Foundation. Active years: 2008-2017.
Company Filing History:
5 out of 726 
1 out of 10 Years Active: 2008-2017
Title: Innovations and Contributions of Inventor Wen-hung Chung
Introduction
Wen-hung Chung is a notable inventor based in Nantou, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of drug reactions and autoimmune disorders. With a total of 5 patents, his work has had a profound impact on patient safety and treatment methodologies.
Latest Patents
One of his latest patents focuses on risk assessment for adverse drug reactions. This invention provides a method for predicting a patient's risk of developing severe reactions, such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). It was discovered that the HLA-B allele, specifically HLA-B*1502, is significantly associated with SJS/TEN induced by various drugs, particularly carbamazepine. Additionally, HLA-B*5801 is linked to SJS/TEN induced by allopurinol, while milder reactions are associated with HLA-B*4601. Genetic markers located between the DRB1 and HLA-A regions of the specific HLA-B haplotype can also be utilized for testing. Another significant patent involves the use of granulysin in diagnosing or treating autoimmune disorders, showcasing his innovative approach to medical challenges.
Career Highlights
Wen-hung Chung has worked with prestigious institutions such as Academia Sinica and Chang Gung Medical Foundation. His research has been pivotal in advancing our understanding of genetic factors in drug reactions and autoimmune diseases.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues, including Yuan-Tsong Chen and Shuen-Iu Hung, who have contributed to his research endeavors.
Conclusion
Wen-hung Chung's innovative work and patents have significantly advanced the fields of pharmacogenetics and autoimmune disorder treatment. His contributions continue to influence medical research and patient care.